These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 30850748)

  • 1. Prospects for pharmacological targeting of pseudokinases.
    Kung JE; Jura N
    Nat Rev Drug Discov; 2019 Jul; 18(7):501-526. PubMed ID: 30850748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudokinases: Prospects for expanding the therapeutic targets armamentarium.
    Devang N; Pani A; Rajanikant GK
    Adv Protein Chem Struct Biol; 2021; 124():121-185. PubMed ID: 33632464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudokinases: update on their functions and evaluation as new drug targets.
    Byrne DP; Foulkes DM; Eyers PA
    Future Med Chem; 2017 Jan; 9(2):245-265. PubMed ID: 28097887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal coordination in kinases and pseudokinases.
    Knape MJ; Herberg FW
    Biochem Soc Trans; 2017 Jun; 45(3):653-663. PubMed ID: 28620027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Looking lively: emerging principles of pseudokinase signaling.
    Sheetz JB; Lemmon MA
    Trends Biochem Sci; 2022 Oct; 47(10):875-891. PubMed ID: 35585008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases.
    Sheetz JB; Mathea S; Karvonen H; Malhotra K; Chatterjee D; Niininen W; Perttilä R; Preuss F; Suresh K; Stayrook SE; Tsutsui Y; Radhakrishnan R; Ungureanu D; Knapp S; Lemmon MA
    Mol Cell; 2020 Aug; 79(3):390-405.e7. PubMed ID: 32619402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide and structural analyses of pseudokinases encoded in the genome of Arabidopsis thaliana provide functional insights.
    Paul A; Srinivasan N
    Proteins; 2020 Dec; 88(12):1620-1638. PubMed ID: 32667690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudokinase drug intervention: a potentially poisoned chalice.
    Claus J; Cameron AJ; Parker PJ
    Biochem Soc Trans; 2013 Aug; 41(4):1083-8. PubMed ID: 23863183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudokinases repurpose flexibility signatures associated with the protein kinase fold for noncatalytic roles.
    Paul A; Subhadarshini S; Srinivasan N
    Proteins; 2022 Mar; 90(3):747-764. PubMed ID: 34708889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of FDA-approved small molecule protein kinase inhibitors.
    Roskoski R
    Pharmacol Res; 2019 Jun; 144():19-50. PubMed ID: 30877063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Techniques to examine nucleotide binding by pseudokinases.
    Lucet IS; Babon JJ; Murphy JM
    Biochem Soc Trans; 2013 Aug; 41(4):975-80. PubMed ID: 23863166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors paradoxically prime kinases.
    Frye SV; Johnson GL
    Nat Chem Biol; 2009 Jul; 5(7):448-9. PubMed ID: 19465930
    [No Abstract]   [Full Text] [Related]  

  • 14. Tracing the origin and evolution of pseudokinases across the tree of life.
    Kwon A; Scott S; Taujale R; Yeung W; Kochut KJ; Eyers PA; Kannan N
    Sci Signal; 2019 Apr; 12(578):. PubMed ID: 31015289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small molecule inhibitor of HER3: a proof-of-concept study.
    Colomba A; Fitzek M; George R; Weitsman G; Roberts S; Zanetti-Domingues L; Hirsch M; Rolfe DJ; Mehmood S; Madin A; Claus J; Kjaer S; Snijders AP; Ng T; Martin-Fernandez M; Smith DM; Parker PJ
    Biochem J; 2020 Sep; 477(17):3329-3347. PubMed ID: 32815546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
    Verkhivker GM
    Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.
    Breen ME; Soellner MB
    ACS Chem Biol; 2015 Jan; 10(1):175-89. PubMed ID: 25494294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances of small molecule targeting of kinases.
    Berndt N; Karim RM; Schönbrunn E
    Curr Opin Chem Biol; 2017 Aug; 39():126-132. PubMed ID: 28732278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.
    Fischer PM
    Med Res Rev; 2017 Mar; 37(2):314-367. PubMed ID: 27775829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining the Protein Kinase Conformational Space with Machine Learning.
    Ung PM; Rahman R; Schlessinger A
    Cell Chem Biol; 2018 Jul; 25(7):916-924.e2. PubMed ID: 29861272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.